Clinical and functional remission even though biologics are superior to conventional DMARDs overall success rates remain low - results from RABBIT, the German biologics register...
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT